Videos

Grand River's Tom Ross

Grand River's Tom Ross

GRAM's president and CEO talks with Contract Pharma.

By Contract Pharma Staff11.12.19
Thomas Ross, president and chief executive officer, Grand River Aseptic Manufacturing, discusses the company's tremendous growth since it first came on the CDMO scene nine years ago.
Related Searches:
Suggested For You
Vetio Animal Health Vetio Animal Health
Contracting And Outsourcing Exhibitor List Contracting And Outsourcing Exhibitor List
Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss
Lonza Breaks Ground on Commercial Drug Product Facility in Stein Lonza Breaks Ground on Commercial Drug Product Facility in Stein
EUROAPI Reports Progressive Restart of Prostaglandin Production EUROAPI Reports Progressive Restart of Prostaglandin Production
Exothera Names Darren Leva as Chief Business Officer Exothera Names Darren Leva as Chief Business Officer
New CDMO Vector BioMed Launches Operations New CDMO Vector BioMed Launches Operations
Mikart Invests in New Liquids and Suspensions Suite Mikart Invests in New Liquids and Suspensions Suite
Pfizer Revenues Soar to Record-Breaking $100B in 2022 Pfizer Revenues Soar to Record-Breaking $100B in 2022
Lilly to Invest $450M at Manufacturing Site in Research Triangle Park Lilly to Invest $450M at Manufacturing Site in Research Triangle Park
Grand River Aseptic Manufacturing Grand River Aseptic Manufacturing
Lonza Further Invests in Drug Product Manufacturing Capabilities Lonza Further Invests in Drug Product Manufacturing Capabilities
Rentschler Biopharma to Support Albert Einstein Discovery Center Rentschler Biopharma to Support Albert Einstein Discovery Center
Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
First Patient is Dosed with Triumvira First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy

Related Buyers Guide Companies

    Loading, Please Wait..